Northeastern to offer free COVID-19 vaccines to students, faculty, staff on Boston campus

The university will offer one-shot Johnson & Johnson vaccines at Cabot Testing Center on Tuesday, May 4 and Wednesday, May 5. Photo by Matthew Modoono/Northeastern University

Northeastern University will offer COVID-19 vaccinations for students, faculty, and staff on the Boston campus over two days in early May, university officials announced this weekend.

The university is working with a local pharmacy to offer Johnson & Johnson’s one-shot vaccine at the Cabot Testing Center on Tuesday, May 4 and Wednesday, May 5, from 10 a.m. to 6 p.m. both days. Students, faculty, staff, and contract workers with an NUID are eligible for vaccinations, and must make an appointment to receive their inoculation, which can be done through the university’s COVID-19 vaccination scheduler online.

Those receiving a vaccine do not need to bring ID, but will be asked to show their completed Daily Wellness Check upon arrival.

“We wanted to help create more avenues for accessibility and essentially bring the pharmacy to our community,” says Christine Civiletto, interim executive director of University Health and Counseling Services. 

“The pharmacy we’re working with informed us that they had Johnson & Johnson vaccine available, and we recognized that for some students, the ability to get one shot before heading home would be beneficial,” she said.

Northeastern requires that all students returning for the fall semester be fully vaccinated against SARS-CoV-2, the coronavirus that causes COVID-19, by their first day of classes.

Ken Henderson, chancellor and senior vice president for learning, encourages all students to get the vaccine—whether on campus or elsewhere—as soon as it becomes available to them, he wrote in a message to students on Friday.

The Johnson & Johnson vaccine, the distribution of which had been temporarily paused earlier this month while public health officials reviewed possible adverse side effects, has been cleared for use once more by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration.

For media inquiries, please contact